Pain Relief for Children During IV Cannulation A Comparison of Lidocaine Spray and EMLA Cream

INTERVENTION: Intervention1: EMLA Cream: Eligible participants were randomly allocated into two groups using a computer‐generated randomization sequence. A standard 20‐gauge intravenous cannula was used for cannulation in all patients. Group E (EMLA Cream): Patients received 2.5 gram of EMLA cream, applied over an area of approximately 20 25 cm on the dorsum of the hand. The application site was covered with an occlusive dressing, and the cream was left in place for at least one hour before cannulation. Control Intervention1: 10 percent Lignocaine spray: Eligible participants were randomly allocated into two groups using a computer‐generated randomization sequence. A standard 20‐gauge intravenous cannula was used for cannulation in all patients. Group L (10 percent Lidocaine Spray): Patients received three sprays of 10 percent lidocaine (total dose 30 mg) over the selected dorsal hand vein. The spray was applied 15 minutes before IV cannulation. CONDITION: Health Condition 1: O‐ Medical and Surgical PRIMARY OUTCOME: The primary outcome measure will be the intensity of pain experienced during IV cannulation via VISUAL ANALOGUE SCALE SCORETimepoint: At the time of venepuncture SECONDARY OUTCOME: secondary outcomes included patient & parental satisfaction & the occurrence of local complicationsTimepoint: At the time of Venepuncture INCLUSION CRITERIA: Child Age 7 to 12 Year ASA grade I or II or III undergoing operative elective procedure under anaesthesia.